Afraid of the backlash, drugmakers are stalling on releasing new drug prices By: MarketWatch April 12, 2017 at 10:38 AM EDT They’re waiting weeks or months after drug approvals to prevent backlash. Read More >> Related Stocks: Biogen Idec Ionis Pharmaceuticals Neurocrine Bioscienc Standard & Poors 500 Teva Pharmaceutical Industries ADR